GB1333339A - Therapeutic compositions - Google Patents

Therapeutic compositions

Info

Publication number
GB1333339A
GB1333339A GB2103772A GB2103772A GB1333339A GB 1333339 A GB1333339 A GB 1333339A GB 2103772 A GB2103772 A GB 2103772A GB 2103772 A GB2103772 A GB 2103772A GB 1333339 A GB1333339 A GB 1333339A
Authority
GB
United Kingdom
Prior art keywords
compositions
therapeutic compositions
medazepam
propantheline
halide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2103772A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1333339A publication Critical patent/GB1333339A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2103772A 1971-05-06 1972-05-05 Therapeutic compositions Expired GB1333339A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14103471A 1971-05-06 1971-05-06

Publications (1)

Publication Number Publication Date
GB1333339A true GB1333339A (en) 1973-10-10

Family

ID=22493866

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2103772A Expired GB1333339A (en) 1971-05-06 1972-05-05 Therapeutic compositions

Country Status (10)

Country Link
US (1) US3714355A (cg-RX-API-DMAC7.html)
AU (1) AU467539B2 (cg-RX-API-DMAC7.html)
BE (1) BE783053A (cg-RX-API-DMAC7.html)
CA (1) CA996466A (cg-RX-API-DMAC7.html)
DE (1) DE2219989A1 (cg-RX-API-DMAC7.html)
ES (1) ES402383A1 (cg-RX-API-DMAC7.html)
FR (1) FR2135300B1 (cg-RX-API-DMAC7.html)
GB (1) GB1333339A (cg-RX-API-DMAC7.html)
NL (1) NL7205578A (cg-RX-API-DMAC7.html)
ZA (1) ZA722262B (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL157802B (nl) * 1969-01-23 1978-09-15 Hoffmann La Roche Werkwijze voor de bereiding van een therapeutisch preparaat voor de behandeling van gastrointestinale ziekten.

Also Published As

Publication number Publication date
AU467539B2 (en) 1973-10-11
CA996466A (en) 1976-09-07
ES402383A1 (es) 1975-04-01
ZA722262B (en) 1972-12-27
FR2135300B1 (cg-RX-API-DMAC7.html) 1975-06-20
US3714355A (en) 1973-01-30
DE2219989A1 (de) 1972-12-07
FR2135300A1 (cg-RX-API-DMAC7.html) 1972-12-15
BE783053A (fr) 1972-11-06
NL7205578A (cg-RX-API-DMAC7.html) 1972-11-08
AU4091172A (en) 1973-10-11

Similar Documents

Publication Publication Date Title
GB1518843A (en) Process for the preparation of hollow particulates
Harada The indication of intravenous gamma globulin for Kawasaki disease
JP3018160B2 (ja) 月経困難症及び/又は月経前症候群の軽減用薬剤
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
US2798837A (en) Achlorhydria composition
IT1244636B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
AU569840B2 (en) Use of oleanolic acid for ulcer treatment
Elwin Some Factors Influencing the Stimulatory Effect of Ethanol on Gastric Acid Secretion during Antrum Application1
Hoskin et al. Controlled‐release morphine in cancer pain: Is a loading dose required when the formulation is changed?
Forbes et al. A 12‐Hour Evaluation of the Analgesic Efficacy of Diflunisal, Zomepirac Sodium, Aspirin, and Placebo in Postoperative Oral Surgery Pain
FR2319346A1 (fr) Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole
Harley et al. Treatment of chronic duodenal ulceration: effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine
IE33949L (en) Therapeutic composition
Gibaldi et al. The pharmacokinetics of penamecillin
Nakajima et al. Inhibitory action of cholecystokinin-pancreozymin on gastric pepsin secretion
Moschella Chemotherapy of psoriasis: ten years of experience
Roberts et al. Postpartum acute myocardial infarction successfully treated with intravenous streptokinase—a case report
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
Bach et al. Rheumatic fever
NO138967B (no) Anordning for forbedring av virkningsgraden i et sentralvarmeanlegg
GB1386927A (en) Preparations for combatting swine dysentery
GB1184110A (en) Compositions for Treating Mental Disorders
Vanderlaan Antithyroid drugs in practice
Engle et al. Single dose (1 gm/kg) gamma globulin: Outcome in 60 consecutive cases of acute Kawasaki disease
GB1327469A (en) Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee